Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma.
Yotsukura M, Yasuda H, Shigenobu T, Kaseda K, Masai K, Hayashi Y, Hishida T, Ohtsuka T, Naoki K, Soejima K, Betsuyaku T, Asamura H.
Yotsukura M, et al. Among authors: masai k.
Lung Cancer. 2017 Jul;109:45-51. doi: 10.1016/j.lungcan.2017.04.014. Epub 2017 Apr 23.
Lung Cancer. 2017.
PMID: 28577949